BDN vs BMY · rev $484.5M vs P/E 17, rev $24.46B
Brandywine Realty Trust (BDN) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Brandywine Realty Trust (BDN) is a reit - office company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported BDN revenue for 2025-12-31 was $484.5M. Net income was -$178.2M. Revenue was down 4.2% from 2024-12-31 to 2025-12-31. BDN currently screens at market cap $719.9M.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BDN currently screens at market cap $719.9M. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BDN and BMY stock pages for the full models.
Not investment advice.